Theileria annulata-transformed cell lines are efficient antigen-presenting cells for in vitro analysis of CD8 T cell responses to bovine herpesvirus-1

Veterinary Research

Volumn 42, Issue 1, 2011, Pages

  Hart, Jane ^a   MacHugh, Niall D ^a   Morrison, W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BOS; BOVINAE; BOVINE HERPESVIRUS 1; CANARYPOX VIRUS; HERPESVIRIDAE; HUMAN HERPESVIRUS 1; POXVIRIDAE; PROTOZOA; THEILERIA ANNULATA;

ANIMAL; ANIMAL DISEASE; ANTIGEN PRESENTING CELL; ARTICLE; BOVINE HERPES VIRUS; CATTLE; CD8+ T LYMPHOCYTE; HERPES VIRUS INFECTION; IMMUNOLOGY; INFECTIOUS BOVINE RHINOTRACHEITIS; THEILERIA ANNULATA; TRANSFORMED CELL LINE; VIROLOGY;

ANIMALS; ANTIGEN-PRESENTING CELLS; CATTLE; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; INFECTIOUS BOVINE RHINOTRACHEITIS; THEILERIA ANNULATA;

EID: 84858114041     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-42-119     Document Type: Article

References (47)

1. + T cell effector mechanisms in resistance to infection. Harty JT, Tvinnereim AR, White DW, Annu Rev Immunol 2003 18 275 308
2. Cloned bovine cytolytic T cells recognize bovine herpes virus-1 in a genetically restricted, antigen-specific manner. Splitter GA, Eskra L, Abruzzini AF, Immunology 1988 63 145 150 2448231
3. Identification of different target glycoproteins for bovine herpes virus type 1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. Denis MS, Keil G, Babiuk LA, Ernst E, Pastoret PP, Thiry E, Immunology 1993 78 7 13 8382189 (Pubitemid 23035842)
4. + T-cell responses to foot-and-mouth disease virus. Childerstone AJ, Cedillo-Baron L, Foster-Cuevas M, Parkhouse RM, J Gen Virol 1999 80 663 669 10092006 (Pubitemid 29101221)
5. + T lymphocytes. Gaddum RM, Cook RS, Furze JM, Ellis SA, Taylor G, Immunology 2003 108 220 229 10.1046/j.1365-2567.2003.01566.x 12562331 (Pubitemid 36232872)
6. + T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. Guzman E, Taylor G, Charleston B, Skinner MA, Ellis SA, J Gen Virol 2008 89 667 675 10.1099/vir.0.83417-0 18272757
7. A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines. Jones C, Chowdhury S, Anim Health Res Rev 2007 8 187 205 10.1017/S146625230700134X 18218160
8. Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood. Hickling JK, Borysiewicz LK, Sissons JG, J Virol 1987 61 3463 3469 2822954 (Pubitemid 17152168)
9. + cytotoxic T-lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. Posavad C, Koelle D, Corey L, J Virol 1996 70 8165 8168 8892947 (Pubitemid 26339132)
10. + T-cell responses during microbial infection. Serbina NV, Pamer EG, Curr Opin Immunol 2003 15 436 442 10.1016/S0952-7915(03)00071-2 12900276 (Pubitemid 36930081)
11. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Gagliard MC, De Petrillo G, Salemi S, Boffa L, Longobardi MG, Dellabona P, Casorati G, Tanigaki N, Harris R, Lanzavecchia A, Int Immunol 1995 7 1741 1752 10.1093/intimm/7.11.1741 8580072
12. + T-cell clones for immunotherapy from the naive repertoire. Ho WY, Nguyen HN, Wolfl M, Kuball J, Greenberg PD, J Immunol Methods 2006 310 40 52 10.1016/j.jim.2005.11.023 16469329 (Pubitemid 43375974)
13. HLA-A2-restricted human CD8(+) cytotoxic T lymphocyte responses to a novel epitope in vaccinia virus that is conserved among orthopox viruses. Dong Y, Denny TN, J Infect Dis 1996 194 168 175
14. Use of Epstein-Barr virus-transformed, autologous B-lymphoblastoid cells as antigen-presenting cells for establishment and maintenance of dengue virus-specific, human cytotoxic T lymphocyte clones. Livingston PG, Kurane I, Ennis FA, J Virol Methods 1997 67 77 84 10.1016/S0166-0934(97)00082-7 9274820 (Pubitemid 27345167)
15. + T cell responses against a cytomegalovirus antigen. Sun Q, Burton RL, Dai L-J, Britt WJ, Lucas KG, J Immunol 2000 165 4105 4111 11034422 (Pubitemid 32057322)
16. Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. Wong DK, Dudley DD, Dohrenwend PB, Lauer GM, Chung RT, Thomas DL, Walker BD, J Virol 2001 75 1229 1235 10.1128/JVI.75.3.1229- 1235.2001 11152496 (Pubitemid 32094682)
17. Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines. Brossart P, Bevan MJ, Blood 1997 90 1594 1599 9269778 (Pubitemid 27355432)
18. Transformation of leukocytes by Theileria parva and T. annulata. Dobbelaere D, Heussler V, Annu Rev Microbiol 1999 53 1 42 10.1146/annurev.micro. 53.1.1 10547684 (Pubitemid 29503724)
19. Interferon production by Theileria annulata-transformed cell lines is restricted to the beta family. Sager H, Brunschwiler C, Jungi TW, Parasite Immunol 1998 20 175 182 10.1046/j.1365-3024.1998.00141.x 9618728 (Pubitemid 28221672)
20. Influence of host and parasite genotypes on immunological control of Theileria parasites. Morrison WI, Parasitology 1996 112 (Suppl):S53 66 8684836
21. Characterization of the fine specificity of bovine CD8 T-cell responses to defined antigens from the protozoan parasite Theileria parva. Graham SP, Pelle R, Yamage M, Mwangi DM, Honda Y, Mwakubambanya RS, de Villiers EP, Abuya E, Awino E, Gachanja J, Mbwika F, Muthiani AM, Muriuki C, Nyanjui JK, Onono FO, Osaso J, Riitho V, Saya RM, Ellis SM, McKeever DJ, MacHugh ND, Gilbert SC, Audonnet J-C, Morrison WI, van der Bruggen P, Taracha ELN, Infect Immun 2008 76 685 694 10.1128/IAI.01244-07 18070892 (Pubitemid 351251740)
22. + T-cell responses to Theileria parva are preferentially directed to a single dominant antigen: Implications for parasite strain-specific immunity. MacHugh ND, Connelley T, Graham SP, Pelle R, Formisano P, Taracha EL, Ellis SA, McKeever DJ, Burrells A, Morrison WI, Eur J Immunol 2009 39 2459 2469 10.1002/eji.200939227 19670382
23. Serological and molecular diversity in the cattle MHC class I region. Ellis S, Morrison WI, MacHugh N, Birch J, Burrells A, Stear M, Immunogenetics 2005 57 601 606 10.1007/s00251-005-0027-8 16086171 (Pubitemid 41397199)
24. Variation in the number of expressed MHC genes in different cattle class I haplotypes. Ellis SA, Holmes EC, Staines KA, Smith KB, Stear MJ, McKeever DJ, MacHugh ND, Morrison WI, Immunogenetics 1999 50 319 328 10.1007/s002510050608 10630296
25. Chemoprophylactic immunization of cattle against Theileria parva (Muguga) and five Theileria strains. Radley DE, Brown CGD, Cunningham MP, Kimber CD, Musisi FL, Payne RC, Purnell RE, Stagg SM, Young AS, Vet Parasitol 1975 1 35 41 10.1016/0304-4017(75)90005-9
26. Techniques for the generation, cloning, and characterisation of bovine cytotoxic T cells specific for the protozoan Theileria parva. Goddeeris BM, Morrison WI, J Tissue Cult Methods 1988 11 101 110 10.1007/BF01404140
27. Infection and transformation of bovine lymphoid cells in vitro by infective particles of Theileria parva. Brown CGD, Stagg DA, Purnell RE, Kanhai GK, Payne RC, Nature 1973 245 101 103 10.1038/245101a0 4200607
28. Characterization of envelope proteins of infectious bovine rhinotracheitis virus (bovine herpesvirus 1) by biochemical and immunological methods. Marshall RL, Rodriguez LL, Letchworth GJ, J Virol 1986 57 745 753 3005625 (Pubitemid 16143952)
29. Determination of lymphocyte division by flow cytometry. Lyons AB, Parish CR, J Immunol Methods 1994 171 131 137 10.1016/0022-1759(94)90236-4 8176234 (Pubitemid 24140219)
30. + T cell helper requirements in Theileria parva-immune and -naive bovine CTL precursors. Taracha EL, Awino E, McKeever DJ, J Immunol 1997 159 4539 4545 9379055 (Pubitemid 127470616)
31. Demonstration of strain-specific CD8 T cell responses to Theileria annulata. MacHugh ND, Burrells AC, Morrison WI, Parasite Immunol 2008 30 385 393 10.1111/j.1365-3024.2008.01038.x 18498311
32. Effects of gamma interferon, tumor necrosis factor alpha, and interleukin-2 on infection and proliferation of Theileria parva-infected bovine lymphoblasts and production of interferon by parasitized cells. DeMartini JC, Baldwin CL, Infect Immun 1991 59 4540 4546 1937812
33. Production of interferons by bovine and ovine cell lines infected with Theileria annulata or Theileria parva. Entrican G, McInnes CJ, Logan M, Preston PM, Martinod S, Brown CG, Parasite Immunol 1991 13 339 343 10.1111/j.1365-3024. 1991.tb00287.x 1712932
34. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus. Johnson R, Glickman R, Yang J, Kaur A, Dion J, Mulligan M, Desrosiers R, J Virol 1997 71 7711 7718 9311855 (Pubitemid 27391716)
35. Theileria annulata and T. parva infect and transform different bovine mononuclear cells. Spooner RL, Innes EA, Glass EJ, Brown G, Immunology 1989 66 284 288 2784413 (Pubitemid 19065808)
36. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Diehl L, den Boer AT, Schoenberger SP, van der Voort EI, Schumacher TN, Melief CJ, Offringa R, Toes RE, Nat Med 1999 5 774 779 10.1038/10495 10395322 (Pubitemid 29318611)
37. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 co-stimulation. Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM, J Exp Med 2004 199 1607 1618 10.1084/jem.20040317 15197224 (Pubitemid 38821994)
38. + T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. Liu T, Khanna KM, Chen X, Fink DJ, Hendricks RL, J Exp Med 2000 191 1459 1466 10.1084/jem.191.9.1459 10790421 (Pubitemid 30257343)
39. In vitro induction of cytotoxic lymphocytes from infectious bovine rhinotracheitis virus hyperimmune cattle. Campos M, Rossi CR, Am J Vet Res 1986 47 2411 2414 3024535
40. Functional signatures of protective antiviral T-cell immunity in human virus infections. Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, Pantaleo G, Immunol Rev 2006 211 236 254 10.1111/j.0105-2896.2006.00395.x 16824132 (Pubitemid 43882976)
41. Induction of cytotoxic T-lymphocytes specific for bovine herpesvirus-1 by DNA immunization. Deshpande MS, Ambagala TC, Hegde NR, Hariharan MJ, Navaratnam M, Srikumaran S, Vaccine 2002 20 3744 3751 10.1016/S0264-410X(02)00375-4 12399204 (Pubitemid 35223405)
42. Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle. Huang Y, Babiuk LA, van Drunen Littel-van den Hurk S, J Gen Virol 2005 86 887 898 10.1099/vir.0.80533-0 15784883 (Pubitemid 40485647)
43. Contributions of nucleotide excision repair, DNA polymerase, and homologous recombination to replication of UV-irradiated herpes simplex virus type 1. Muylaert I, Elias P, J Biol Chem 2010 285 13761 13768 10.1074/jbc.M110.107920 20215648
44. + T cell responses. Yewdell JW, Immunity 2006 25 533 543 10.1016/j.immuni.2006.09.005 17046682 (Pubitemid 44529047)
45. The bovine autologous Theileria mixed leukocyte reaction: Influence of monocytes and phenotype of the parasitised stimulator cell on proliferation and parasite specificity. Goddeeris BM, Morrison WI, Immunology 1987 60 63 69 2950050 (Pubitemid 17230141)
46. + T lymphocytes are stimulated to proliferate by autologous Theileria annulata-infected cells in the presence of interleukin-2. Collins RA, Sopp P, Gelder KI, Morrison WI, Howard CJ, Scand J Immunol 1996 44 444 452 10.1046/j.1365-3083.1996.d01-332.x 8947595 (Pubitemid 26382326)
47. Cell surface phenotype of two cloned populations of bovine lymphocytes displaying non-specific cytotoxic activity. Goddeeris BM, Dunlap S, Bensaid A, MacHugh ND, Morrison WI, Vet Immunol Immunopathol 1991 27 195 199 10.1016/0165-2427(91)90100-Q 1826981